New Formulation Doubles Vaccine Shelf Life Without Refrigeration
Hyderabad based biotech firm ImmunoGene, with ICMR support, developed a stabilizer compound that keeps vaccines viable at up to 40°C for 60 days. This breakthrough reduces cold chain reliance, especially for rural immunization drives. COVID 19 booster and measles vaccines using this tech are already in pre approval testing. WHO has taken interest for global deployment in low resource nations.
WNBA stars aim for All Star redemption 
Hydrogen Fuel Cell Innovation 
Citigroup sets mid 2026 MSCI ACWI target at 1,150, expecting 5% market growth 
Heritage Building Restoration Gets Green Light, Preserving City’s History 
Wales rugby slump continues